In the past 10 years, anti-TNFs indications have expanded to include non-radiographic axial spondyloarthritis (AxSpA), paediatric enthesitis-related arthritis, paediatric ulcerative colitis (UC), hidradenitis suppurativa (including adolescents) and non-infectious uveitis (including children) (Table 1)
Why Do Researchers Combine CJC-1295 and Ipamorelin
Differential effects between marimastat, a TNF- converting enzyme inhibitor, and anti-TNF- antibody on murine models for sepsis and arthritis
5-Amino-1MQ is designed precisely for this phenotype
Holly Wyatt: Our state-of-slimmers know this
Rather than cannibalizing significant market share from injectables, oral formulations are more likely to expand the total patient population eligible for these therapies